Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic mice.
We and others have previously demonstrated that treatment with bone marrow derived DC genetically modified to express IL-4 reduce disease pathology in mouse models of collagen-induced arthritis and delayed-type hypersensitivity. Moreover, treatment of normoglycemic NOD mice with bone marrow derived...
Main Authors: | Melanie A Ruffner, Paul D Robbins |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-07-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2912295?pdf=render |
Similar Items
-
Polygenic control of autoimmune diabetes in nonobese diabetic mice.
by: Ghosh, S, et al.
Published: (1993) -
Assessment of mean platelet volume in diabetes mellitus and its correlation with hba1c in normoglycemic, diabetic and prediabetic status
by: Athira KP, et al.
Published: (2023-07-01) -
Altered expression of synaptic proteins and adhesion molecules in the hippocampus and cortex following the onset of diabetes in nonobese diabetic mice
by: Takumi Yokokawa, et al.
Published: (2023-04-01) -
Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice
by: Marcos Iglesias, et al.
Published: (2018-07-01) -
Estimation of novel anthropometric measurements among normoglycemic persons, prediabetes, and diabetes in the Indian population: An analytical cross-sectional study
by: C A Jayashankar, et al.
Published: (2023-01-01)